Risperidone in the treatment of psychotic depression

Chanoch Miodownik, Vladimir Lerner

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

Original languageEnglish
Pages (from-to)335-337
Number of pages3
JournalClinical Neuropharmacology
Issue number6
StatePublished - 1 Dec 2000


  • 5HT receptors
  • Monotherapy
  • Psychotic depression
  • Risperidone
  • α2-adrenergic affinities


Dive into the research topics of 'Risperidone in the treatment of psychotic depression'. Together they form a unique fingerprint.

Cite this